Drug profile · INN
atazanavir + cobicistat
EVOTAZ
atazanavir + cobicistat (EVOTAZ) is an FDA-listed pharmaceutical active ingredient. Associated with Bristol-Myers Squibb Australia Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — atazanavir + cobicistat
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
atazanavir + cobicistat (EVOTAZ) is an FDA-listed pharmaceutical active ingredient. Associated with Bristol-Myers Squibb Australia Pty Ltd.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is atazanavir + cobicistat?
atazanavir + cobicistat (EVOTAZ) is an FDA-listed pharmaceutical active ingredient. Associated with Bristol-Myers Squibb Australia Pty Ltd.
What is the brand name for atazanavir + cobicistat?
EVOTAZ is a marketed brand name for atazanavir + cobicistat. Check FDA Drugs@FDA for the current US label holder and prescribing information.